- Home
- NVNI vs CRVO Comparison
NVNI vs CRVO Comparison
Compare NVNI & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVNI
- CRVO
- Stock Information
- Founded
- NVNI 2019
- CRVO 2001
- Country
- NVNI Brazil
- CRVO United States
- Employees
- NVNI N/A
- CRVO N/A
- Industry
- NVNI
- CRVO Biotechnology: Pharmaceutical Preparations
- Sector
- NVNI
- CRVO Health Care
- Exchange
- NVNI Nasdaq
- CRVO Nasdaq
- Market Cap
- NVNI 57.2M
- CRVO 65.2M
- IPO Year
- NVNI N/A
- CRVO N/A
- Fundamental
- Price
- NVNI $3.23
- CRVO $6.92
- Analyst Decision
- NVNI
- CRVO Strong Buy
- Analyst Count
- NVNI 0
- CRVO 6
- Target Price
- NVNI N/A
- CRVO $21.50
- AVG Volume (30 Days)
- NVNI 274.9K
- CRVO 69.5K
- Earning Date
- NVNI 09-30-2025
- CRVO 11-12-2025
- Dividend Yield
- NVNI N/A
- CRVO N/A
- EPS Growth
- NVNI N/A
- CRVO N/A
- EPS
- NVNI N/A
- CRVO N/A
- Revenue
- NVNI $31,250,627.00
- CRVO $7,776,968.00
- Revenue This Year
- NVNI $12.05
- CRVO N/A
- Revenue Next Year
- NVNI $15.02
- CRVO N/A
- P/E Ratio
- NVNI N/A
- CRVO N/A
- Revenue Growth
- NVNI 1491.58
- CRVO N/A
- 52 Week Low
- NVNI $1.44
- CRVO $1.80
- 52 Week High
- NVNI $121.90
- CRVO $16.94
- Technical
- Relative Strength Index (RSI)
- NVNI 51.43
- CRVO 39.74
- Support Level
- NVNI $3.17
- CRVO $6.78
- Resistance Level
- NVNI $3.47
- CRVO $7.78
- Average True Range (ATR)
- NVNI 0.32
- CRVO 0.40
- MACD
- NVNI -0.17
- CRVO 0.05
- Stochastic Oscillator
- NVNI 13.76
- CRVO 20.41
About NVNI Nvni Group Limited
Nvni Group Ltd is a holding company that conducts all of its business through Nuvini SA and Nuvini acquired companies. Nuvini S.A. acquires and operates software companies within SaaS markets in Brazil. Nuvini S.A. is the private serial software business acquirer in Brazil and intends to use funding and capital markets access to continue expanding its acquisition plans in Brazil and Latin America. The Company has determined that it has a single operating and reportable segment which is multi-vertical SaaS solution model.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.